Medtronic co-founder Earl Bakken, a pioneer in medical technology whose inventions impacted countless lives, died Sunday in Hawaii at age 94.
NuVasive took analysts by surprise Friday with the announcement that CEO, Greg Lucier will soon be replaced by Chris Barry.
FDA has approved the use of Abbott's Heartmate 3 device for advanced heart failure patients who are not eligible for a transplant. These patients will live with their device for the rest of their life.
It's been a full year since Abbott closed its $5.3 billion acquisition of Alere, a deal that almost didn't happen.
Abbott's product pipeline is stronger than ever, but there is one little elephant in the room as the company looks ahead to 2019.
ConvaTec's shares plunged Monday after the advanced wound care leader drastically lowered its revenue expectations and announced the sudden departure of CEO Paul Moraviec.
A report posted in FDA's MedSun database describes two heart pumps that were returned to the manufacturer for investigation.
Medtronic has issued a software update to address cybersecurity vulnerabilities associated with the Internet connection between two models of CareLink programmers used to download software from the company's network.
The Pacific Research Institute released a new study that points to five core tax principles and how the 2.3% medical device tax violates each.
The Utah Supreme Court will decide whether to apply to medical devices a key legal doctrine that protects manufacturers of technologically-advanced products from the unfair application of strict liability.
Using a prototype to do some informal bench testing will help you write clear and objective design inputs, according to an expert speaking at MD&M Minneapolis.
A Cleveland Clinic surgeon talks about the future potential of a new single-port robotic surgery system.